ES2115584T3 - Antigeno sintetico para la deteccion de enfermedades referentes al sida. - Google Patents
Antigeno sintetico para la deteccion de enfermedades referentes al sida.Info
- Publication number
- ES2115584T3 ES2115584T3 ES87310047T ES87310047T ES2115584T3 ES 2115584 T3 ES2115584 T3 ES 2115584T3 ES 87310047 T ES87310047 T ES 87310047T ES 87310047 T ES87310047 T ES 87310047T ES 2115584 T3 ES2115584 T3 ES 2115584T3
- Authority
- ES
- Spain
- Prior art keywords
- aids
- diseases
- referring
- detection
- synthetic antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000030507 AIDS Diseases 0.000 title abstract 2
- 108010008038 Synthetic Vaccines Proteins 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 239000010836 blood and blood product Substances 0.000 abstract 1
- 229940125691 blood product Drugs 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/22—Viral peptide or viral protein
- Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- AIDS & HIV (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE PROPORCIONAN NUEVOS PEPTIDOS QUE TIENEN PRACTICAMENTE LA MISMA SECUENCIA QUE FRAGMENTOS INMUNOLOGICANMENTE SIGNIFICATIVOS DE VIRUS RELACIONADOS CON EL SIDA. LOS POLIPEPTIDOS SE PUEDEN UTILIZAR COMO REACTIVOS EN LA DETERMINACION DE LA EXPOSICION DE UN HUESPED HUMANO AL VIRUS. DE ESPECIAL INTERES ES EL USO DE LOS POLIPEPTIDOS EN EL TAMIZADO DE PRODUCTOS SANGUINEOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/930,785 US5075211A (en) | 1986-03-26 | 1986-11-14 | Synthetic antigen for the detection of AIDS-related disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2115584T3 true ES2115584T3 (es) | 1998-07-01 |
Family
ID=25459766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87310047T Expired - Lifetime ES2115584T3 (es) | 1986-11-14 | 1987-11-13 | Antigeno sintetico para la deteccion de enfermedades referentes al sida. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5075211A (es) |
EP (1) | EP0267802B1 (es) |
JP (1) | JP2886861B2 (es) |
AT (1) | ATE163766T1 (es) |
AU (1) | AU616383B2 (es) |
CA (1) | CA1340097C (es) |
DE (1) | DE3752170T2 (es) |
DK (1) | DK174533B1 (es) |
ES (1) | ES2115584T3 (es) |
IE (1) | IE81132B1 (es) |
NO (1) | NO173958C (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7273695B1 (en) * | 1984-10-31 | 2007-09-25 | Novartis Vaccines And Diagnostics, Inc. | HIV immunoassays using synthetic envelope polypeptides |
US5128319A (en) | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
US6210873B1 (en) | 1987-08-28 | 2001-04-03 | Board Of Regents, The University Of Texas System | Methods and compositions for the priming of specific cytotoxic T-lymphocyte response |
FR2632310B1 (fr) * | 1988-06-06 | 1992-04-10 | Pasteur Institut | Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles |
ZA896768B (en) * | 1988-09-09 | 1990-06-27 | Akzo Nv | Synthetic polypeptides immunochemically reactive with hiv-antibodies |
US5439792A (en) * | 1989-06-02 | 1995-08-08 | Genetic Systems Corporation | Cysteine thiol-protected peptides for use in immunoassays |
ATE141956T1 (de) * | 1989-07-11 | 1996-09-15 | Gen Probe Inc | Verfahren zur vervielfältigung von nukleinsäuresequenzen |
US6589734B1 (en) | 1989-07-11 | 2003-07-08 | Gen-Probe Incorporated | Detection of HIV |
US5627035A (en) * | 1990-08-22 | 1997-05-06 | Syntello Vaccine Development Ab | Peptides that block human immunodeficiency virus and methods of use thereof |
SE9101863D0 (sv) * | 1991-06-13 | 1991-06-13 | Replico Medical Ab | Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar |
AU657590B2 (en) * | 1991-11-04 | 1995-03-16 | Dade International Inc. | Synthetic peptides corresponding to portions of HIV-2 virus and methods of using in an improved assay |
US6667387B1 (en) * | 1996-09-30 | 2003-12-23 | N.V. Innogenetics S.A. | HCV core peptides |
SG77551A1 (en) * | 1992-03-06 | 2005-04-28 | Innogenetics Nv | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing |
US6709828B1 (en) | 1992-03-06 | 2004-03-23 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
US6632613B1 (en) * | 1993-06-02 | 2003-10-14 | University Of Utah Research Foundation | Compositions and kits for fluorescence polarization assay of large molecules |
US6479055B1 (en) * | 1993-06-07 | 2002-11-12 | Trimeris, Inc. | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
US5603933A (en) * | 1993-08-31 | 1997-02-18 | Board Of Regents, The University Of Texas | CD4 peptides for binding to viral envelope proteins |
DE69433427T2 (de) * | 1993-12-09 | 2004-09-16 | The University Of Utah Research Foundation, Salt Lake City | Zusammensetzungen und kits zur fluoreszenzpolarisierungsdosierung von grossen molekülen |
ATE467690T1 (de) * | 1997-08-01 | 2010-05-15 | Bio Rad Laboratories | Synthetisches antigen zum nachweis von hiv- immunreaktiven antikörpern |
GB9717652D0 (en) * | 1997-08-20 | 1997-10-22 | Nycomed Imaging As | Method |
US6656471B1 (en) | 1998-11-17 | 2003-12-02 | Board Of Regents, The University Of Texas System | HIV-specific T-cell induction |
EP1422298B1 (en) * | 1999-07-09 | 2010-01-27 | Gen-Probe Incorporated | Detection of hiv-1 by nucleic acid amplification |
US6582920B2 (en) * | 2000-09-01 | 2003-06-24 | Gen-Probe Incorporated | Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations |
KR101933685B1 (ko) * | 2018-06-29 | 2018-12-28 | 주식회사 에스알바이오텍 | 약물이 코팅된 마이크로 니들 및 이의 제조방법 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ207394A (en) * | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
GB8324800D0 (en) * | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
US4716102A (en) * | 1984-08-15 | 1987-12-29 | Regents Of The University Of California | Purified AIDS-associated virus ARV-2 |
US9328391B1 (en) * | 1984-08-22 | 2016-05-03 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Cloning and expression of HIV-1 DNA |
DE3587181T2 (de) * | 1984-10-18 | 1993-06-24 | Centre Nat Rech Scient | F antigene vom menschlichen immunodefizienz-virus und deren verwendungen. |
CA1341423C (en) * | 1984-10-31 | 2003-03-04 | Paul A. Luciw | Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
JPS61233700A (ja) * | 1984-12-24 | 1986-10-17 | ジエネンテク,インコ−ポレイテツド | 分子クロ−ンされたエイズ関連ポリペプチド |
DE3650011T2 (de) * | 1985-04-08 | 1994-11-17 | Genetic Systems Corp | EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND. |
DE3650175T3 (de) * | 1985-04-29 | 2007-09-06 | Bio-Rad Laboratories, Inc., Hercules | Synthetische antigene zum nachweis von aids. |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
US4661445A (en) * | 1985-05-24 | 1987-04-28 | Saxinger W Carl | Competitive ELISA for the detection of HTLV-III antibodies |
US4704357A (en) * | 1985-09-30 | 1987-11-03 | United States Of America As Represented By The Department Of Health And Human Services | Immortalized T-lymphocyte cell line for testing HTLV-III inactivation |
CS256960B1 (en) * | 1985-11-16 | 1988-04-15 | Viktor Krchnak | Peptides with properties of antigenic determinants and method of their production |
JPS62164696A (ja) * | 1986-01-06 | 1987-07-21 | エフ.ホフマン ― ラ ロシュ アーゲー | HTLV−3gag遺伝子の発現 |
US4734362A (en) * | 1986-02-03 | 1988-03-29 | Cambridge Bioscience Corporation | Process for purifying recombinant proteins, and products thereof |
JPS63503356A (ja) * | 1986-05-20 | 1988-12-08 | ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク | ヒトt細胞リンパ球向性ウイルス(htlv‐3)逆転写酵素の発現及びその使用 |
-
1986
- 1986-11-14 US US06/930,785 patent/US5075211A/en not_active Expired - Lifetime
-
1987
- 1987-11-13 DK DK198705977A patent/DK174533B1/da not_active IP Right Cessation
- 1987-11-13 IE IE307387A patent/IE81132B1/en not_active IP Right Cessation
- 1987-11-13 AT AT87310047T patent/ATE163766T1/de not_active IP Right Cessation
- 1987-11-13 EP EP87310047A patent/EP0267802B1/en not_active Expired - Lifetime
- 1987-11-13 NO NO874740A patent/NO173958C/no not_active IP Right Cessation
- 1987-11-13 ES ES87310047T patent/ES2115584T3/es not_active Expired - Lifetime
- 1987-11-13 JP JP62287207A patent/JP2886861B2/ja not_active Expired - Lifetime
- 1987-11-13 DE DE3752170T patent/DE3752170T2/de not_active Expired - Lifetime
- 1987-11-13 CA CA000551770A patent/CA1340097C/en not_active Expired - Lifetime
- 1987-11-13 AU AU81211/87A patent/AU616383B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IE873073L (en) | 1988-05-14 |
AU616383B2 (en) | 1991-10-31 |
EP0267802A2 (en) | 1988-05-18 |
DE3752170D1 (de) | 1998-04-09 |
DK174533B1 (da) | 2003-05-12 |
NO173958B (no) | 1993-11-15 |
DE3752170T2 (de) | 1998-10-08 |
AU8121187A (en) | 1988-05-19 |
ATE163766T1 (de) | 1998-03-15 |
JPS63221247A (ja) | 1988-09-14 |
DK597787D0 (da) | 1987-11-13 |
NO874740D0 (no) | 1987-11-13 |
US5075211A (en) | 1991-12-24 |
JP2886861B2 (ja) | 1999-04-26 |
NO874740L (no) | 1988-05-16 |
EP0267802A3 (en) | 1991-03-06 |
IE81132B1 (en) | 2000-03-22 |
EP0267802B1 (en) | 1998-03-04 |
CA1340097C (en) | 1998-10-20 |
NO173958C (no) | 1994-02-23 |
DK597787A (da) | 1988-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2115584T3 (es) | Antigeno sintetico para la deteccion de enfermedades referentes al sida. | |
DK626486A (da) | Syntetiske antigener til afsloering af aids-relateret sygdom | |
ES8708058A1 (es) | Un metodo para detectar la presencia de virus lav-htlv-iii o de anticuerpo para virus lav-htlv-iii | |
ES2128362T3 (es) | Fragmentos de proteinas de prion. | |
DK614987A (da) | Syntetiske htlv-iii peptider, praeparater og anvendelser deraf | |
NO870412D0 (no) | Peptider. | |
ES2013328A6 (es) | Un metodo para detectar anticuerpos contra antigenos hiv-1. | |
IT7967166A0 (it) | Reagente per saggi immunologici e procedimento per la sua preparazione | |
DK173883D0 (da) | Substituerede 8-phenylxanthiner | |
DE69131482D1 (en) | Phosphotyrosin phosphatase als neuer rezeptor-typ | |
AR210753A1 (es) | Composicion de diagnostico mejorada para la deteccion del antigeno de superficie de hepatitis b en la sangre humana | |
ES2058259T3 (es) | Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2. | |
KR890700683A (ko) | 인체 면역 결핍 바이러스에 대한 항체 검색 방법 | |
ES539638A0 (es) | Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b | |
DE69841664D1 (de) | Synthetisches Antigen zum Nachweis von HIV-immunreaktiven Antikörpern | |
ES2074707T3 (es) | Anticuerpos monoclonales que distinguen entre proteinas naturales y proteinas con secuencias modificadas. | |
IT1196501B (it) | Polipeptide utile per la preparazione di vaccini per la malaria e di kits diagnostici per la determinazione di affezioni malariche | |
SE8305667L (sv) | Adenokarcinomrelaterade nya antigena determinanter och antikroppar som er specifika for dessa, forfarande for deras framstellning samt reagenssystem henforande sig till dem | |
NO874807L (no) | Membranaffinitets konsentrasjons-immunoanalyse. | |
DE3788424D1 (de) | Testverfahren des menschlichen b-lymphotropen virus (hblv). | |
KR870013036U (ko) | 발 살 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 267802 Country of ref document: ES |